Moderate doses of Thiamine y Biotin for huntington disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Jul 2020: Trial registered, NCT04478734
  2. 12 Apr 2023: Trial started, NCT04478734

The trials

NCT04478734: Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease

State
Under way
Phase
Phase 2
People
24 planned
Started
12 Apr 2023
Primary completion
30 Jun 2025
Arms
Moderate doses
Results
None posted
  1. 21 Jul 2020: Trial registered
  2. 12 Apr 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.